Science Current Events | Science News | Brightsurf.com
 
corner top left block corner top right

Tuberculosis drug shows promise against latent bacteria

September 15, 2008

Appearing in the Sept. 12 issue of JBC

A new study has shown that an investigational drug (R207910, currently in clinical trials against multi-drug resistant tuberculosis strains) is quite effective at killing latent bacteria. This revelation suggests that R207910 may lead to improved and shortened treatments for this globally prevalent disease.

Despite numerous treatment advances, tuberculosis (TB) remains a serious disease -fueled by co-infection of HIV patients, the rise of drug-resistant strains, and the ability of Mycobacterium tuberculosis to become dormant and linger in the lungs. In fact, one third of the world population is infected, asymptomatically, with latent TB and is at risk of developing active TB disease during their life time.

Anil Koul and colleagues at Johnson & Johnson tested R207910 on dormant M. tuberculosis in three different laboratory models of latency. R207910 targets a protein (ATP synthase) essential for making cellular energy (ATP) in actively replicating TB. The researchers reasoned that even dormant bacteria, which are essentially physiologically "turned off", still need to produce small quantities of ATP to survive. As such, a block in ATP synthesis might be an Achilles heel for killing dormant bacteria.

This reasoning proved to be correct and R207190 was able to kill dormant bacteria by greater than 95% whereas current drugs like isoniazid had no effect. Surprisingly, they found that R207910 is slightly more effective in killing dormant bacteria as compared to actively replicating ones, a unique spin as all known TB drugs are more effective on replicating bugs. Koul and colleagues hope to validate these results clinically, and note that ATP synthase should be looked at as a drug target for other persistent bacterial infections.

American Society for Biochemistry and Molecular Biology




The White Plague: Tuberculosis, Man and Society

The White Plague: Tuberculosis, Man and Society
by Jean Dubos (Author)




Tuberculosis and Nontuberculous Mycobacterial Infections

Tuberculosis and Nontuberculous Mycobacterial Infections
by David Schlossberg (Editor)


Here's an up-to-date 4th Edition of the resource that discusses tuberculosis at a time when major outbreaks and drug-resistant strains of the disease are making headlines.

The Forgotten Plague: How the Battle Against Tuberculosis Was Won - And Lost

The Forgotten Plague: How the Battle Against Tuberculosis Was Won - And Lost
by Frank Ryan (Author)


Ryan, a physician, offers a history of the cure for tuberculosis, including accounts of the people and scientists involved. The final chapter spells out a renewed threat in the congruence of AIDS and tuberculosis.

Invincible Microbe: Tuberculosis and the Never-Ending Search for a Cure

Invincible Microbe: Tuberculosis and the Never-Ending Search for a Cure
by Jim Murphy (Author), Alison Blank (Author)


This is the story of a killer that has been striking people down for thousands of years:
tuberculosis. After centuries of ineffective treatments, the microorganism that causes
TB was identified, and the cure was thought to be within reach—but drug-resistant
varieties continue to plague and panic the human race. The “biography” of this deadly
germ, an account of the diagnosis, treatment, and “cure” of the disease over time,
and the social history of an illness that could strike anywhere but was most prevalent
among the poor are woven together in an engrossing, carefully researched narrative.
Bibliography, source notes, index.

Tuberculosis: A Comprehensive Clinical Reference, 1e

Tuberculosis: A Comprehensive Clinical Reference, 1e
by H. Simon Schaaf MBChB(Stellenbosch) MMed Paed(Stellenbosch) DCM(Stellenbosch) MD Paed(Stellenbosch) (Editor), Alimuddin Zumla BSc.MBChB.MSc.PhD.FRCP(Lond).FRCP(Edin).FRCPath(UK) (Editor)


This book provides all the vital information you need to know about tuberculosis, especially in the face of drug-resistant strains of the disease. Coverage includes which patient populations face an elevated risk of infection, as well as which therapies are appropriate and how to correctly monitor ongoing treatment so that patients are cured. Properly administer screening tests, interpret their results, and identify manifestations of the disease, with authoritative guidance from expert clinicians from around the world.Discusses screening tests for tuberculosis so you can interpret their results and identify not only common manifestations of the disease, but also those that are comparatively rare-such as tuberculosis in pregnant women.
Covers all clinical aspects of tuberculosis in...

A Child of Sanitariums: A Memoir of Tuberculosis Survival and Lifelong Disability

A Child of Sanitariums: A Memoir of Tuberculosis Survival and Lifelong Disability
by Gloria Paris (Author)


This dramatic memoir recounts one woman's experience with skeletal tuberculosis, which she contracted at the age of five in the 1930s. It recounts her next nine years living in tuberculosis sanatoriums where she underwent many treatments for the disease and was finally released when she was 14. Despite her subsequent disablement, she went on to marry and have three children, work as a micro-biologist, perform as a comedienne, and serve as an advocate for minority groups. By turns deeply affecting and hilarious, this memoir provides a glimpse into a still-dangerous disease and is a testament to the power of human perseverance and hope.

The Return of the White Plague: Global Poverty and the "New" Tuberculosis

The Return of the White Plague: Global Poverty and the "New" Tuberculosis
by Matthew Gandy (Editor), Alimuddin Zumla (Editor)


A global health catastrophe threatens to undermine all efforts to eradicate poverty and human suffering.The dramatic increase since the 1980s in the global prevalence of tuberculosis, a disease destined as recently as thirty years ago for complete eradication, is a story of medical failure. A pandemic whose geography defies simple categorization, it ranges from schools in the UK to prisons in Russia, from refugee camps in central Africa to affluent suburbs in North America. The 'new' tuberculosis is derived from a combination of different developments such as collapsing health-care services, shifting patterns of poverty and inequality, the spread of HIV, and the emergence of virulent drug-resistant strains. This collection provides an international survey of current thought on the spread...

Captain of Death: The Story of Tuberculosis

Captain of Death: The Story of Tuberculosis
by Thomas M. Daniel (Author)


The dramatic story of tuberculosis is told here in a straightforward and accessible style. It presents the stories of persons connected with the disease, either as victims, or as those who made contributions to our knowledge of it; in addition to these personal accounts, the book unfolds the history and explains the pathogenesis of TB. The re-emergence of tuberculosis as a major American public health hazard has focused much attention on this ancient disease. This book offers a comprehensive account of the disease from prehistoric times through to the present day, detailing the attempts to eradicate it completely. Its four separate sections (the spread of tuberculosis; its infectious nature; susceptibility to it; and methods of treatment) are linked through the device of presenting...

Tuberculosis

Tuberculosis


TUBERCULOSIS

Last updated 2/25/2012

Table of Contents
- Background, Statistics, Epidemiology
- Method of Spread
- Pathophysiology
- History
- Risk factors
- Differential Diagnosis
- Physical Exam
- Workup
- Treatment
- More to come

The Bioarchaeology of Tuberculosis: A Global View on a Reemerging Disease

The Bioarchaeology of Tuberculosis: A Global View on a Reemerging Disease
by CHARLOTTE ROBERTS (Author), JANE BUIKSTRA (Author)


Though apparently in decline during the first half of the 20th century, tuberculosis has reawakened in both developed and developing countries, particularly among susceptible populations with immunodeficiency disorders.

corner bottom left corner bottom right
© 2012 BrightSurf.com